Sedana Medical: Initial take on Q4 2022 results - Redeye

Redeye provides an initial take on Sedana Medical’s Q4 results, and we are optimistic about the sales coming in 12% above our forecast and in line with our estimates for adjusted EBITDA. We will return shortly with a more in-depth take on the report and fair value range changes.

Länk till analysen i sin helhet: https://www.redeye.se/research/878494/sedana-medical-initial-take-on-q4-2022-results?utm_source=finwire&utm_medium=RSS